What is Mesa Laboratories Inc worth?
With the base-case assumptions below, a discounted cash flow model on Mesa Laboratories Inc's reported free cash flow gives $203.00 per share. The share price was $134.04 on September 25, 2026, 34% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 8.0% | 10.0% | $121.15 | -10% |
| Base | 13.0% | 9.0% | $203.00 | +51% |
| Bull | 18.0% | 8.0% | $355.51 | +165% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $264.33 | $283.37 | $306.64 | $335.73 | $373.14 |
| 8.0% | $218.32 | $230.66 | $245.26 | $262.77 | $284.18 |
| 9.0% | $184.81 | $193.25 | $203.00 | $214.36 | $227.79 |
| 10.0% | $159.38 | $165.39 | $172.19 | $179.97 | $188.94 |
| 11.0% | $139.46 | $143.87 | $148.79 | $154.32 | $160.59 |
Where the presets come from
Base: years 1 to 5 grow at Mesa Laboratories Inc's revenue growth rate over the last 5 fiscal years (13.2% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions